Related references
Note: Only part of the references are listed.Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma
Hongping Xia et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Re-evaluation of the diagnostic performance of 11C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomas
Dongwoo Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers
Jee Soo Park et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Correlation of 18F-FDG and 11C-methionine uptake on PET/CT with Ki-67 immunohistochemistry in newly diagnosed intracranial meningiomas
Katsuya Mitamura et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results
Moritz Schwyzer et al.
LUNG CANCER (2018)
Methionine coordinates a hierarchically organized anabolic program enabling proliferation
Adhish S. Walvekar et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron emission Tomography imaging in Gliomas
Kamalakannan Palanichamy et al.
FRONTIERS IN ONCOLOGY (2017)
Metabolic PET Imaging in Oncology
Kiran Kumar Solingapuram Sai et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
Tomoya Mizuno et al.
BMC CANCER (2015)
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
Hiromi I. Wettersten et al.
CANCER RESEARCH (2015)
Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT
Miwako Takahashi et al.
CLINICAL NUCLEAR MEDICINE (2015)
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas
Yoshifumi Noda et al.
EUROPEAN RADIOLOGY (2015)
Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis
Sheng-ming Deng et al.
PLOS ONE (2015)
HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma
Bo Qiu et al.
CANCER DISCOVERY (2015)
Standardized Uptake Values Highly Correlate with Tumor Size and Fuhrman Grade in Patients with Clear Cell Renal Cell Carcinoma
Emre Can Polat et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Restaging Clear Cell Renal Carcinoma With 18F-FDG PET/CT
Chiara Fuccio et al.
CLINICAL NUCLEAR MEDICINE (2014)
Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma
Francesco Gatto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
Hironori Betsunoh et al.
BMC CANCER (2013)
Value of 11C-methionine PET in imaging brain tumours and metastases
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma
Hsin-Yi Wang et al.
CANCER IMAGING (2012)
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses
Tamer Ozulker et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer
S. A. Sohaib et al.
BRITISH JOURNAL OF RADIOLOGY (2009)
Visualization of small glottic laryngeal cancer using methyl-labeled 11C-methionine positron emission tomography
J. Wedman et al.
ORAL ONCOLOGY (2009)
Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity
T. Kato et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prognostic value of histologic subtypes in renal cell carcinoma:: A multicenter experience
JJ Patard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
DE Kang et al.
JOURNAL OF UROLOGY (2004)
Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases:: a comparison with CT
N Aide et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma
JC Cheville et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Imaging gliomas with positron emission tomography and single-photon emission computed tomography
F Bénard et al.
SEMINARS IN NUCLEAR MEDICINE (2003)
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
S Ramdave et al.
JOURNAL OF UROLOGY (2001)